TY - JOUR AU - Bray, F. AU - Ferlay, J. AU - Soerjomataram, I. AU - Siegel, R. L. AU - Torre, L. A. AU - Jemal, A. PY - 2018 DA - 2018// TI - Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries JO - CA. VL - 68 ID - Bray2018 ER - TY - JOUR AU - Colecchia, A. AU - Schiumerini, R. AU - Cucchetti, A. AU - Cescon, M. AU - Taddia, M. AU - Marasco, G. AU - Festi, D. PY - 2014 DA - 2014// TI - Prognostic factors for hepatocellular carcinoma recurrence JO - World J Gastroenterol VL - 20 UR - https://doi.org/10.3748/wjg.v20.i20.5935 DO - 10.3748/wjg.v20.i20.5935 ID - Colecchia2014 ER - TY - STD TI - EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. Eur J Cancer. 2012; 48(5):599–641. ID - ref3 ER - TY - JOUR AU - Dhir, M. AU - Melin, A. A. AU - Douaiher, J. AU - Lin, C. AU - Zhen, W. K. AU - Hussain, S. M. AU - Geschwind, J. F. AU - Doyle, M. B. AU - Abou-Alfa, G. K. AU - Are, C. PY - 2016 DA - 2016// TI - A review and update of treatment options and controversies in the management of hepatocellular carcinoma JO - Ann Surg VL - 263 UR - https://doi.org/10.1097/SLA.0000000000001556 DO - 10.1097/SLA.0000000000001556 ID - Dhir2016 ER - TY - JOUR AU - Roayaie, S. AU - Blume, I. N. AU - Thung, S. N. AU - Guido, M. AU - Fiel, M. I. AU - Hiotis, S. AU - Labow, D. M. AU - Llovet, J. M. AU - Schwartz, M. E. PY - 2009 DA - 2009// TI - A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma JO - Gastroenterology VL - 137 UR - https://doi.org/10.1053/j.gastro.2009.06.003 DO - 10.1053/j.gastro.2009.06.003 ID - Roayaie2009 ER - TY - JOUR AU - Imamura, H. AU - Matsuyama, Y. AU - Tanaka, E. AU - Ohkubo, T. AU - Hasegawa, K. AU - Miyagawa, S. AU - Sugawara, Y. AU - Minagawa, M. AU - Takayama, T. AU - Kawasaki, S. PY - 2003 DA - 2003// TI - Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy JO - J Hepatol VL - 38 UR - https://doi.org/10.1016/S0168-8278(02)00360-4 DO - 10.1016/S0168-8278(02)00360-4 ID - Imamura2003 ER - TY - JOUR AU - Zhang, X. AU - Li, J. AU - Shen, F. AU - Lau, W. Y. PY - 2018 DA - 2018// TI - Significance of presence of microvascular invasion in specimens obtained after surgical treatment of hepatocellular carcinoma JO - J Gastroenterol Hepatol VL - 33 UR - https://doi.org/10.1111/jgh.13843 DO - 10.1111/jgh.13843 ID - Zhang2018 ER - TY - JOUR AU - Li, Z. AU - Lei, Z. AU - Xia, Y. AU - Li, J. AU - Wang, K. AU - Zhang, H. AU - Wan, X. AU - Yang, T. AU - Zhou, W. AU - Wu, M. PY - 2018 DA - 2018// TI - Association of preoperative antiviral treatment with incidences of microvascular invasion and early tumor recurrence in hepatitis B virus-related hepatocellular carcinoma JO - JAMA surgery VL - 153 UR - https://doi.org/10.1001/jamasurg.2018.2721 DO - 10.1001/jamasurg.2018.2721 ID - Li2018 ER - TY - JOUR AU - Lim, K. C. AU - Chow, P. K. AU - Allen, J. C. AU - Chia, G. S. AU - Lim, M. AU - Cheow, P. C. AU - Chung, A. Y. AU - Ooi, L. L. AU - Tan, S. B. PY - 2011 DA - 2011// TI - Microvascular invasion is a better predictor of tumor recurrence and overall survival following surgical resection for hepatocellular carcinoma compared to the Milan criteria JO - Ann Surg VL - 254 UR - https://doi.org/10.1097/SLA.0b013e31821ad884 DO - 10.1097/SLA.0b013e31821ad884 ID - Lim2011 ER - TY - JOUR AU - Rodriguez-Peralvarez, M. AU - Luong, T. V. AU - Andreana, L. AU - Meyer, T. AU - Dhillon, A. P. AU - Burroughs, A. K. PY - 2013 DA - 2013// TI - A systematic review of microvascular invasion in hepatocellular carcinoma: diagnostic and prognostic variability JO - Ann Surg Oncol VL - 20 UR - https://doi.org/10.1245/s10434-012-2513-1 DO - 10.1245/s10434-012-2513-1 ID - Rodriguez-Peralvarez2013 ER - TY - JOUR AU - Wang, Y. Y. AU - Wang, L. J. AU - Xu, D. AU - Liu, M. AU - Wang, H. W. AU - Wang, K. AU - Zhu, X. AU - Xing, B. C. PY - 2019 DA - 2019// TI - Postoperative adjuvant transcatheter arterial chemoembolization should be considered selectively in patients who have hepatocellular carcinoma with microvascular invasion JO - HPB VL - 21 UR - https://doi.org/10.1016/j.hpb.2018.08.001 DO - 10.1016/j.hpb.2018.08.001 ID - Wang2019 ER - TY - JOUR AU - Wang, L. AU - Chen, B. AU - Li, Z. AU - Yao, X. AU - Liu, M. AU - Rong, W. AU - Wu, F. AU - Lin, S. AU - Liu, Y. AU - Zheng, Y. PY - 2019 DA - 2019// TI - Optimal postoperative adjuvant treatment strategy for HBV-related hepatocellular carcinoma with microvascular invasion: a propensity score analysis JO - OncoTargets Therapy VL - 12 UR - https://doi.org/10.2147/OTT.S179247 DO - 10.2147/OTT.S179247 ID - Wang2019 ER - TY - JOUR AU - Wang, L. AU - Wang, W. AU - Yao, X. AU - Rong, W. AU - Wu, F. AU - Chen, B. AU - Liu, M. AU - Lin, S. AU - Liu, Y. AU - Wu, J. PY - 2017 DA - 2017// TI - Postoperative adjuvant radiotherapy is associated with improved survival in hepatocellular carcinoma with microvascular invasion JO - Oncotarget VL - 8 UR - https://doi.org/10.18632/oncotarget.20402 DO - 10.18632/oncotarget.20402 ID - Wang2017 ER - TY - JOUR AU - Xiao, H. AU - Chen, Z. B. AU - Jin, H. L. AU - Li, B. AU - Xu, L. X. AU - Guo, Y. AU - Chen, S. L. AU - Li, H. P. AU - Peng, Z. W. AU - Shen, J. X. PY - 2019 DA - 2019// TI - Treatment selection of recurrent hepatocellular carcinoma with microvascular invasion at the initial hepatectomy JO - Am J Transl Res VL - 11 ID - Xiao2019 ER - TY - JOUR AU - Wei, W. AU - Jian, P. E. AU - Li, S. H. AU - Guo, Z. X. AU - Zhang, Y. F. AU - Ling, Y. H. AU - Lin, X. J. AU - Xu, L. AU - Shi, M. AU - Zheng, L. PY - 2018 DA - 2018// TI - Adjuvant transcatheter arterial chemoembolization after curative resection for hepatocellular carcinoma patients with solitary tumor and microvascular invasion: a randomized clinical trial of efficacy and safety JO - Cancer Commun VL - 38 UR - https://doi.org/10.1186/s40880-018-0331-y DO - 10.1186/s40880-018-0331-y ID - Wei2018 ER - TY - JOUR AU - Wang, H. AU - Du, P. C. AU - Wu, M. C. AU - Cong, W. M. PY - 2018 DA - 2018// TI - Postoperative adjuvant transarterial chemoembolization for multinodular hepatocellular carcinoma within the Barcelona Clinic Liver Cancer early stage and microvascular invasion JO - Hepatob Surg Nutr VL - 7 UR - https://doi.org/10.21037/hbsn.2018.09.05 DO - 10.21037/hbsn.2018.09.05 ID - Wang2018 ER - TY - JOUR AU - Ye, J. Z. AU - Chen, J. Z. AU - Li, Z. H. AU - Bai, T. AU - Chen, J. AU - Zhu, S. L. AU - Li, L. Q. AU - Wu, F. X. PY - 2017 DA - 2017// TI - Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion JO - World J Gastroenterol VL - 23 UR - https://doi.org/10.3748/wjg.v23.i41.7415 DO - 10.3748/wjg.v23.i41.7415 ID - Ye2017 ER - TY - JOUR AU - Liu, J. Y. PY - 2016 DA - 2016// TI - Li chuan, Wen TF, Yan LN, Yang JY, Li Bo, Wang WT, Xu MQ, Wu H: Prognosis of surgery excision combined with interventional therapy in treatment of hepatocellular carcinoma with microvascular invasion JO - J Reg Anat Oper Surg VL - 25 ID - Liu2016 ER - TY - JOUR AU - Sun, J. J. AU - Wang, K. AU - Zhang, C. Z. AU - Guo, W. X. AU - Shi, J. AU - Cong, W. M. AU - Wu, M. C. AU - Lau, W. Y. AU - Cheng, S. Q. PY - 2016 DA - 2016// TI - Postoperative adjuvant transcatheter arterial chemoembolization after R0 hepatectomy improves outcomes of patients who have hepatocellular carcinoma with microvascular invasion JO - Ann Surg Oncol VL - 23 UR - https://doi.org/10.1245/s10434-015-5008-z DO - 10.1245/s10434-015-5008-z ID - Sun2016 ER - TY - JOUR AU - Liu, C. AU - Sun, L. AU - Xu, J. AU - Zhao, Y. PY - 2016 DA - 2016// TI - Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma JO - World J Surg Oncol VL - 14 UR - https://doi.org/10.1186/s12957-016-0855-z DO - 10.1186/s12957-016-0855-z ID - Liu2016 ER - TY - JOUR AU - Jin, Y. J. AU - Lee, J. W. AU - Lee, O. H. AU - Chung, H. J. AU - Kim, Y. S. AU - Lee, J. I. AU - Cho, S. G. AU - Jeon, Y. S. AU - Lee, K. Y. AU - Ahn, S. I. PY - 2014 DA - 2014// TI - Transarterial chemoembolization versus surgery/radiofrequency ablation ablation for recurrent hepatocellular carcinoma with or without microvascular invasion JO - J Gastroenterol Hepatol VL - 29 UR - https://doi.org/10.1111/jgh.12507 DO - 10.1111/jgh.12507 ID - Jin2014 ER - TY - JOUR AU - Qi, Y. P. AU - Zhong, J. H. AU - Liang, Z. Y. AU - Zhang, J. AU - Chen, B. AU - Chen, C. Z. AU - Li, L. Q. AU - Xiang, B. D. PY - 2019 DA - 2019// TI - Adjuvant transarterial chemoembolization for patients with hepatocellular carcinoma involving microvascular invasion JO - Am J Surg VL - 217 UR - https://doi.org/10.1016/j.amjsurg.2018.07.054 DO - 10.1016/j.amjsurg.2018.07.054 ID - Qi2019 ER - TY - JOUR AU - Huang, Y. AU - Zhang, Z. AU - Zhou, Y. AU - Yang, J. AU - Hu, K. AU - Wang, Z. PY - 2019 DA - 2019// TI - Should we apply sorafenib in hepatocellular carcinoma patients with microvascular invasion after curative hepatectomy? JO - OncoTargets Therapy VL - 12 UR - https://doi.org/10.2147/OTT.S187357 DO - 10.2147/OTT.S187357 ID - Huang2019 ER - TY - JOUR AU - Liao, M. AU - Zhu, Z. AU - Wang, H. AU - Huang, J. PY - 2017 DA - 2017// TI - Adjuvant transarterial chemoembolization for patients after curative resection of hepatocellular carcinoma: a meta-analysis JO - Scand J Gastroenterol VL - 52 UR - https://doi.org/10.1080/00365521.2017.1292365 DO - 10.1080/00365521.2017.1292365 ID - Liao2017 ER - TY - STD TI - Xiang X, Lau WY, Wu ZY, Zhao C, Ma YL, Xiang BD, Zhu JY, Zhong JH, Li LQ: Transarterial chemoembolization versus best supportive care for patients with hepatocellular carcinoma with portal vein tumor thrombusa multicenter study. Eur J Surg Oncol 2019. ID - ref25 ER - TY - JOUR AU - Bai, T. AU - Chen, J. AU - Xie, Z. B. AU - Wu, F. X. AU - Wang, S. D. AU - Liu, J. J. AU - Li, L. Q. PY - 2016 DA - 2016// TI - The efficacy and safety of postoperative adjuvant transarterial embolization and radiotherapy in hepatocellular carcinoma patients with portal vein tumor thrombus JO - OncoTargets Therapy VL - 9 UR - https://doi.org/10.2147/OTT.S113832 DO - 10.2147/OTT.S113832 ID - Bai2016 ER - TY - JOUR AU - Yu, W. AU - Wang, W. AU - Rong, W. AU - Wang, L. AU - Xu, Q. AU - Wu, F. AU - Liu, L. AU - Wu, J. PY - 2014 DA - 2014// TI - Adjuvant radiotherapy in centrally located hepatocellular carcinomas after hepatectomy with narrow margin (<1 cm): a prospective randomized study JO - J Am Coll Surg VL - 218 UR - https://doi.org/10.1016/j.jamcollsurg.2013.11.030 DO - 10.1016/j.jamcollsurg.2013.11.030 ID - Yu2014 ER - TY - STD TI - Cho YK. A randomized trial comparing radiofrequency ablation ablation and surgical resection for HCC conforming to the Milan criteria. Ann Surg. 2011; 254(5):838–839 (author reply 839) ID - ref28 ER - TY - JOUR AU - Ferrari, F. S. AU - Megliola, A. AU - Scorzelli, A. AU - Stella, A. AU - Vigni, F. AU - Drudi, F. M. AU - Venezia, D. PY - 2007 DA - 2007// TI - Treatment of small HCC through radiofrequency ablation ablation and laser ablation. Comparison of techniques and long-term results JO - La Radiologia medica VL - 112 UR - https://doi.org/10.1007/s11547-007-0148-2 DO - 10.1007/s11547-007-0148-2 ID - Ferrari2007 ER - TY - STD TI - Seror O, N’Kontchou G, Ganne N, Beaugrand M: A randomized trial comparing radiofrequency ablation ablation and surgical resection for HCC conforming to the Milan criteria. Ann Surg 2011; 254(5):837 (author reply 837–838). ID - ref30 ER - TY - JOUR AU - Llovet, J. M. AU - Bisceglie, A. M. AU - Bruix, J. AU - Kramer, B. S. AU - Lencioni, R. AU - Zhu, A. X. AU - Sherman, M. AU - Schwartz, M. AU - Lotze, M. AU - Talwalkar, J. PY - 2008 DA - 2008// TI - Design and endpoints of clinical trials in hepatocellular carcinoma JO - J Natl Cancer Inst VL - 100 UR - https://doi.org/10.1093/jnci/djn134 DO - 10.1093/jnci/djn134 ID - Llovet2008 ER - TY - JOUR AU - Kim, D. W. AU - Talati, C. AU - Kim, R. PY - 2017 DA - 2017// TI - Hepatocellular carcinoma (HCC): beyond sorafenib-chemotherapy JO - J Gastroint Oncol VL - 8 UR - https://doi.org/10.21037/jgo.2016.09.07 DO - 10.21037/jgo.2016.09.07 ID - Kim2017 ER - TY - JOUR AU - Moher, D. AU - Liberati, A. AU - Tetzlaff, J. AU - Altman, D. G. PY - 2010 DA - 2010// TI - Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement JO - Int J Surg VL - 8 UR - https://doi.org/10.1016/j.ijsu.2010.02.007 DO - 10.1016/j.ijsu.2010.02.007 ID - Moher2010 ER - TY - JOUR AU - Stang, A. PY - 2010 DA - 2010// TI - Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses JO - Eur J Epidemiol VL - 25 UR - https://doi.org/10.1007/s10654-010-9491-z DO - 10.1007/s10654-010-9491-z ID - Stang2010 ER - TY - JOUR AU - Ioannidis, J. P. AU - Patsopoulos, N. A. AU - Evangelou, E. PY - 2007 DA - 2007// TI - Heterogeneity in meta-analyses of genome-wide association investigations JO - PLoS ONE VL - 2 UR - https://doi.org/10.1371/journal.pone.0000841 DO - 10.1371/journal.pone.0000841 ID - Ioannidis2007 ER - TY - JOUR AU - Egger, M. AU - Davey Smith, G. AU - Schneider, M. AU - Minder, C. PY - 1997 DA - 1997// TI - Bias in meta-analysis detected by a simple, graphical test JO - BMJ VL - 315 UR - https://doi.org/10.1136/bmj.315.7109.629 DO - 10.1136/bmj.315.7109.629 ID - Egger1997 ER - TY - JOUR AU - Yamashita, Y. AU - Tsuijita, E. AU - Takeishi, K. AU - Fujiwara, M. AU - Kira, S. AU - Mori, M. AU - Aishima, S. AU - Taketomi, A. AU - Shirabe, K. AU - Ishida, T. PY - 2012 DA - 2012// TI - Predictors for microinvasion of small hepatocellular carcinoma